Lundbeck

Headquartered in Copenhagen, this international pharmaceutical company develops and markets drugs to treat neurological and psychological disorders. We first worked with H. Lundbeck A/S as Teva’s comarketing partner on the Azilect launch, and now we work with Lundbeck Inc. through the acquisition of Ovation Pharmaceuticals and its epilepsy drug, Sabril.